Few stocks have repriced as sharply as Arm in 2026. After bottoming near $105 in mid-January, shares climbed to the edge of their all-time high on a strong fiscal Q4 report and a multibillion-dollar AI data center backlog. The question is whether that move has run too far.
Our 24/7 Wall St. price target for Arm (NASDAQ: ARM | ARM Price Prediction) is $160.19 over the next 12 months, implying meaningful downside from current levels. The proprietary model rates conviction high, and the recommendation is sell. Arm remains structurally important, but valuation has outrun fundamentals.
24/7 Wall St. Price Target Summary
| Metric | Value |
|---|---|
| Current Price | $212.99 |
| 24/7 Wall St. Price Target | $160.19 |
| Upside/Downside | -32.9% |
| Recommendation | SELL |
| Confidence Level | 90% |
Why We Could Be Wrong
Our price target sits well below current levels, and Arm is one of the most divisive names in semis. Real upside could come from the $15 billion AGI CPU revenue opportunity management is targeting by 2031, or from faster-than-expected royalty step-ups as Armv9 penetrates servers.
How a 126% Rally Reset the Setup
Arm is up 17.66% in the last week, 59.51% over the past month, and 117.09% year to date.
Shares jumped 13.63% on May 6 after fiscal Q4 revenue of $1.49 billion (+20.1% YoY) beat the $1.47 billion consensus and non-GAAP EPS of $0.60 topped the $0.58 estimate. Licensing surged 29% and royalties rose 11%, with full-year FY2026 revenue of $4.92 billion (+23%). The catalyst is the Arm AGI CPU, which has already secured more than $2 billion in customer demand across FY2027 to FY2028.
The Case for $230+
Bulls have a credible roadmap. UBS lifted its target to $245, projecting Arm-based shipments will hit 40% to 45% of the server CPU market by 2030 as that TAM expands from $30 billion to roughly $170 billion. Wells Fargo sits at $220, and one bull case from TIKR.com models a $576 price by 2030.
Real demand backs this: Google’s next-gen TPU8t and TPU8i replacing x86 with custom Arm-based Axion CPUs, NVIDIA’s Vera CPU, and AGI CPU integrations from Cerebras, OpenAI, Positron, and Rebellions. If royalties compound and AGI CPU economics approach silicon margins rather than license fees, the bull scenario points to roughly $230.
The Risks Worth Watching
The bear case starts with valuation. Arm trades at a 318 P/E and 100x forward earnings, with the stock at 99.8% of its 52-week high. TSMC fully exited its 1.11 million share stake for roughly $231 million, and CEO Rene Haas plus CFO Jason Child were part of around $13.6 million in Q4 insider sales.
Non-GAAP operating margin compressed from 52.8% to 49.1% as R&D rose 33% YoY to $493 million. R&D ramp funds AGI CPU development, but with Q1 FY2027 guidance of just $1.26 billion in revenue and a Qualcomm trial in Q4 calendar 2026, the bear scenario lands near $139.
Hold Fire at These Levels
Our price target on Arm is $160.19, the recommendation is sell, and confidence is 90%. The gap between forward EPS of $1.06 and a triple-digit forward multiple tips the scale. The model would turn more constructive if AGI CPU revenue hits the P&L ahead of the 2028 timeline and royalty rates step up further, and more cautious if Q1 FY2027 guidance marks the start of a digestion year. For now, the risk-reward profile remains skewed to the downside.
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $160 |
| 2027 | $150 |
| 2028 | $140 |
| 2029 | $128 |
| 2030 | $117 |
These projections assume Arm executes on its current strategy and multiples normalize as the AGI CPU ramp matures. Significant upside or downside could result from AGI CPU revenue arriving before 2028, a Qualcomm trial outcome, or a step-change in royalty economics from Armv9.
Top Gaining Stocks
Top Losing Stocks